Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dartmet-PG1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Addii Biotech Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Dartmet-PG1 Tablet ER

Glycemia-Control ER tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen. Take with food to prevent gastric distress. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double a dose; overdose risks hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals may cause hypoglycemia (low blood sugar). Regular blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your physician of any kidney, liver, or heart conditions before starting treatment. Pregnant or lactating individuals should seek medical advice prior to use. Kidney function will be assessed before initiating therapy. Limit alcohol consumption as it may exacerbate side effects.

Uses of Dartmet-PG1 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Dartmet-PG1 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or divide it. Dartmet-PG1 Extended-Release Tablet should be administered with a meal.

Common Side effects of Dartmet-PG1 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Dartmet-PG1 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Dartmet-PG1 Extended-Release Tablets should be administered with a meal.

How Dartmet-PG1 Tablet ER works:

Dartmet-PG1 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to optimize blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dartmet-PG1 Tablet ER and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Dartmet-PG1 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Dartmet-PG1 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Dartmet-PG1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Dartmet-PG1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Dartmet-PG1 Tablet ER. Dosage modification of Dartmet-PG1 Tablet ER might be necessary. Physician consultation is advised. Dartmet-PG1 Tablet ER is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Dartmet-PG1 Tablet ER :

Should you forget a Dartmet-PG1 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dartmet-PG1 Tablet ER

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Dartmet-PG1 Tablet ER

Consuming alcohol while taking Dartmet-PG1 Tablet ER is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and raise your risk of lactic acidosis.
Tell your doctor before taking Dartmet-PG1 Tablet ER if you have congestive heart failure, kidney or liver problems, or swelling behind your eye. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you take, including prescriptions, over-the-counter drugs, vitamins, and herbal supplements.
Yes, Dartmet-PG1 Tablet ER, containing metformin, can lead to vitamin B12 deficiency due to its long-term interference with vitamin B12 absorption in the stomach.
Dartmet-PG1 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as candy or chocolate.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Dartmet-PG1 Tablet ER
69
MRP 80
13% off